Drug Approval | July 15, 2022
U.S. FDA grants emergency use authorization for Novavax COVID-19 vaccine
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
MINYM can be safely used by patients above 9 years of age.
The appointments will add to the well-diversified experience that currently exists on the PPL board.
The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
The company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
Lacosamide Injection is used to treat partial-onset seizures.
Subscribe To Our Newsletter & Stay Updated
